These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7052665)
41. [Familial dystonia transformed by the bromocriptine]. Sabouraud O; Allain H; Pinel JF; Menault F Nouv Presse Med; 1978 Oct; 7(37):3370. PubMed ID: 733517 [No Abstract] [Full Text] [Related]
42. Identification of a highly polymorphic microsatellite VNTR within the argininosuccinate synthetase locus: exclusion of the dystonia gene on 9q32-34 as the cause of dopa-responsive dystonia in a large kindred. Kwiatkowski DJ; Nygaard TG; Schuback DE; Perman S; Trugman JM; Bressman SB; Burke RE; Brin MF; Ozelius L; Breakefield XO Am J Hum Genet; 1991 Jan; 48(1):121-8. PubMed ID: 1985454 [TBL] [Abstract][Full Text] [Related]
43. [The differentiated treatment of dystonia musculorum deformans in children]. Mal'mberg SA Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):33-6. PubMed ID: 7908772 [TBL] [Abstract][Full Text] [Related]
44. Hereditary progressive dystonia with marked diurnal fluctuation--consideration on its pathophysiology based on the characteristics of clinical and polysomnographical findings. Segawa M; Nomura Y; Tanaka S; Hakamada S; Nagata E; Soda M; Kase M Adv Neurol; 1988; 50():367-76. PubMed ID: 3041759 [No Abstract] [Full Text] [Related]
46. The treatment of dystonia with L-dopa and haloperidol. Mandell S Neurology; 1970 Nov; 20(11):103-6. PubMed ID: 5529471 [No Abstract] [Full Text] [Related]
47. Carbamazepine in torsion in dystonia. Isgreen WP; Fahn S; Barrett RE; Snider SR; Chutorian AM Adv Neurol; 1976; 14():411-6. PubMed ID: 941781 [No Abstract] [Full Text] [Related]
48. Preliminary remarks on the L-dopa therapy of dystonia. Coleman M Neurology; 1970 Nov; 20(11):114-21. PubMed ID: 5529473 [No Abstract] [Full Text] [Related]
49. Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa. Barrett RE; Yahr MD; Duvoisin RC Neurology; 1970 Nov; 20(11):107-13. PubMed ID: 5529472 [No Abstract] [Full Text] [Related]
50. Neurosurgical treatment of dystonia. Cooper IS Neurology; 1970 Nov; 20(11):133-48. PubMed ID: 5529475 [No Abstract] [Full Text] [Related]
51. [Dystonia musculorum deformans. Elements of a favorable development]. Visier JP; Maury M; Maurin C; Ronfort R; Frerebeau P; Rejou F; Echenne B Arch Fr Pediatr; 1984; 41(7):493-5. PubMed ID: 6497558 [TBL] [Abstract][Full Text] [Related]
56. [Copper metabolism and dystonia musculorum deformans. Biochemical, clinical and neuropathological considerations apropos of a case]. De Lellis M; Rosini MP; Frascarelli M; Palladini G Riv Neurobiol; 1973; 19(3-4):207-18. PubMed ID: 4807532 [No Abstract] [Full Text] [Related]
57. Amelioration of severe torsion dystonia with perphenazine. Harel D; Giladi N Isr J Med Sci; 1990 Oct; 26(10):590-2. PubMed ID: 2249940 [No Abstract] [Full Text] [Related]
59. [The use of levodopa in diseases other than Parkinsonism]. Barbeau A Union Med Can; 1972 May; 101(5):849-52. PubMed ID: 4666887 [No Abstract] [Full Text] [Related]
60. [Effect of some neurotropic substances on the nature of the blood sugar curves in torsion dystonia]. Amos EG; Korkhov VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1491-5. PubMed ID: 5490135 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]